In this context, the selective inhibition of the uPAR/FPR1 interaction could facilitate the development of selective inhibitors of the processes sustained by a chronic excess of cell migration, such as inflammatory diseases, tumor spread and metastases, without affecting other functions regulated by FPR1. The gene discussed is FPR1; the disease is neoplasm.